An update on Chagas disease (human American trypanosomiasis)

REFERENCES

• Aché, A. & Matos, A. (2001). Interrupting Chagas disease transmission in Venezuela. Revista do Institut° de Medicina Tropical de Sao Paulo, 43, 37–43.
   PubMedGoogle Scholar
• Andrade, A. L., Zicker, F., Oliveira, R. M., Silva, S. A., Luquetti, A., Trabaos, L. R., Almeida, I. C., Andrade, S. S., Andrade, J. G. & Martelli, C. M. T. (1996). Randomized trial of efficacy of benznida-zole in treatment of early Trypanosoma cruzi infection. Lancet, 348, 1407–1413.
   PubMed Web of Science ®Google Scholar
• Andrade, S. G. (1974). Caracterizaçáo de cepas do Trypanosoma cruzi isoladas do Reciincavo Baiano. Revista de Patologia Tropical, 3, 65–121.
   Google Scholar
• Andrade, Z. (2000). Patologia da doenca de Chagas. In Trypanosoma cruzi e Doença de Chagas, eds Brener, Z., Andrade, Z. A. & Barral-Neto, M. pp. 201-230. Rio de Janeiro, Brazil: Guanabara-Koogan.
   Google Scholar
• Afiez, N., Carrasco, H., Parada, H., Crisante, G., Rojas, A., Fuenmayor, C., Gonzalez, N. Percoco, G., Borges, R., Guevara, P. & Ramirez, J. L. (1999). Myocardial parasite persistence in chronic chagasic patients. American Journal of Tropical Medicine and Hygiene, 60, 726-732.
   Google Scholar
• Anon. (1991). Reunion de Ministros de Salud del MERCOSUR, Brasilia, Juni° 1991, Resolución 04-3-CS. Montevideo: Mercado Comnn del Sur.
   Google Scholar
• Chagas, C. (1909). Nova tripanozomiase humana. Estudos sobre a morfolojia e o ciclo evolutivo de Schizotgpanum cruzi n.gen., n.sp., ajente etiolójico de nova entidade morbida do homen. Membrias do Institut° Oswaldo Cruz, 1, 159–218.
   Google Scholar
• Coura, J. R., Abreu, L. L., Pereira, J. B. & Willcox, H. P. F. (1985). Morbidade da doenca de Chagas, IV. Estudo longitudinal de dez anos em Pains e Iguatama, Minas Gerais, Brasil. Memorias do Institut° Oswaldo Cruz, 80, 73-80.
   Google Scholar
• Di Noia, J. M., d'Orso, I., Ekslund, L., Sanchez, D. O. & Frasch, A. C. C. (1998). The Trypanosoma cruzi mucin family is transcribed from hundreds of genes having hypervariable regions. Journal of Biological Chemistry, 273, 10,843-10,850.
   Google Scholar
• El-Sayed, N. M., Myler, P. J., Bartholomeu, D. C., Nilsson, D., Aggarwal, G., Tran, A. N., Ghedin, E., Worthey, E. A., Delcher, A. L., Blandin, G., Westenberger, S. J., Caler, E., Cerqueira, G. C., Branche, C., Haas, B., Anupama, A., Arner, E., Aslund, L., Attipoe, P., Bontempi, E., Bringaud, F., Burton, P., Cadag, E., Campbell, D. A., Carrington, M., Crabtree, J., Darban, H., da Silveira, J. F., de Jong, P., Edwards, K., Englund, P. T., Fazelina, G., Feldblyum, T., Ferella, M., Frasch, A. C., Gull, K., Horn, D., Hou, L., Huang, Y., Kindlund, E., Klingbeil, M., Kluge, S., Koo, H., Lacerda, D., Levin, M. J., Lorenzi, H., Louie, T., Machado, C. R., McCulloch, R., McKenna, A., Mizuno, Y., Mottram, J. C., Nelson, S., Ochaya, S., Osoegawa, K., Pai, G., Parsons, M., Pentony, M., Pettersson, U., Pop, M., Ramirez, J. L., Rinta, J., Robertson, L., Salzberg, S. L., Sanchez, D. O., Seyler, A., Sharma, R., Shetty, J., Simpson, A. J., Sisk, E., Tammi, M. T., Tarleton, R., Teixeira, S., Van Aken, S., Vogt, C., Ward, P. N., Wickstead, B., Wortman, J., White, O., Fraser, C. M., Stuart, K. D. & Andersson, B. (2005). The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science, 309, 409-415.
   Google Scholar
• Fernandes, O., Souto, J. A., Castro, J. B., Pereira, N. C., Fernandes, A. C., Junqueira, R. D., Naiff, T. V., Barrett, W., Degrave, W., Zingales, B., Campbell, D. A. & Coura, J. R (1998). Brazilian isolates of Trypanosoma cruzi from humans and triatomines classified into two lineages using mini-exon and ribosomal RNA sequences. American Journal of Tropical Medicine and Hygiene, 58, 807–811.
   PubMed Web of Science ®Google Scholar
• Grant, I. H., Gold, J. W. & Witmer, M. (1989). Transfusion-associated acute Chagas disease acquired in the United States. Annals of Internal Medicine, 111, 849–851.
   PubMed Web of Science ®Google Scholar
• Guhl, F. & Schofield, C. J. (eds) (2004). Proceedings of an International Workshop on Chagas Disease Surveillance in the Amazon Region. Bogota: Universidad de Los Andes.
   Google Scholar
• Hanke, J., Frohme, M., Laurent, J. P., Swindle, J. & Hoheisel, J. D. (1998). Hybridization mapping of Trypanosoma cruzi chromosomes III and IV. Electrophoresis, 4, 482–485.
   Google Scholar
• Henriksson, J., Porcel, B., Rydaker, M., Ruiz, A., Sabaj, V., Galanti, N., Cazzulo, J. J., Frasch, A. C. & Pettersson, U. (1995). Chromosome specific markers reveal conserved linkage groups in spite of extensive chromosomal size variation in Trypanosoma cruzi. Molecular Biochemistry and Parasitology, 73, 63–74.
   PubMed Web of Science ®Google Scholar
• Higuchi, M. L., Gutierrez, P., Aiello, V. D., Palomino, S., Bocchi, E. A., Kalil, J., Bellotti, G. & Pileggi, F. (1993). Immunohistochemical character-ization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Archiv, 423, 157–60.
   Google Scholar
• Higuchi, M. L., Ries, M. M., Aiello, V. D., Benvenuti, L. A., Gutierrez, P. S., Bellotti, G. & Pileggi, F. (1997). Association of an increase in CD8 + T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. American Journal of Tropical Medicine and Hygiene, 56, 485-489.
   Google Scholar
• Jones, E. M., Colley, D. G., Tostes, S., Lopes, E. R., Vnencak-Jones, C. L. & McCurley, T. L. (1992). A Trypanosoma cruzi DNA sequence amplified from inflammatory lesions in human chagasic cardiomyo-pathy. Transactions of the Association of American Physicians, 105, 182–189.
   PubMedGoogle Scholar
• Kierszenbaum, F. (1999). Chagas' disease and the autoimmunity hypothesis. Clinical Microbiology Reviews, 12, 210–223.
   PubMed Web of Science ®Google Scholar
• Kirchhoff, L., Gamm, A. A. & Gilliam, F. C. (1987). American trypanosomiasis (Chagas disease) in Central American immigrants. American Journal of Medicine, 82, 915.
   Google Scholar
• Liendo, A., Lazardi, K. & Urbina, J. A. (1998). In vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi. Journal of Antimicrobial Chemotherapy, 41, 197–205.
   PubMed Web of Science ®Google Scholar
• Miles, M. A., Lanham, S. M., Souza, A. A. & Povoa, M. (1980). Further enzymic characters of Trypanosoma cruzi and their evaluation for strain identification. Transactions of the Royal Society of Tropical Medicine and Hygiene, 74, 221–242.
   PubMed Web of Science ®Google Scholar
• Moncayo, A. & Luquetti, A. O. (1990). Multicentric double blind study for evaluation of Trypanosoma cruzi defined antigens as diagnostic reagents. Memórias do Institut° Oswaldo Cruz, 85, 489–495.
   PubMed Web of Science ®Google Scholar
• Morel, C. M., Chiari, E., Plessmann Carnargo, E., Mattei, D. M., Romanha, A. J. & Simpson, L. (1980). Strains and clones of Trypanosoma cruzi can be characterized by restriction endonuclease finger-printing of kinetoplast DNA minicircles. Proceedings of the National Academy of Sciences of the United States of America, 77, 6810-6814.
   Google Scholar
• Morel, C. M., Acharya, T., Broun, D., Dangi, A., Elias, C., Ganguly, N. K., Gardner, C. A., Gupta, R. K., Haycock, J., Heher, A. D., Hotez, P. J.,
   Google Scholar
• Kettler, H. E., Keusch, G. T., Krattiger, A. F., Kreutz, F. T., Lall, S., Lee, K., Mahoney, R., Martinez-Palomo, A., Mashelkar, R. A., Matlin, S. A., Mzimba, M., Oehler, J., Ridley, R. G., Senanayake, P., Singer, P. & Yun, M. (2005). Health innovation network to help developing coun-tries address neglected diseases. Science, 309, 401–404.
   PubMed Web of Science ®Google Scholar
• Mufloz, P., Thiermann, E., Attias, A. & Acevedo, C. (1992). Enfermedad de Chagas congénita sintomd-tica en recién nacidos y lactantes. Revista Chilena de Pediatria, 65, 196–202.
   Google Scholar
• Pan American Health Organization (1999). Tratamiento Etiologic° de la Enfermedad de Chagas, Conclusiones de una Consulta Técnica. Document PS/HCP/HCT/140/ 99. Washington, DC: PAHO.
   Google Scholar
• Pereira, J. B., Willcox, H. P. & Coura, J. R. (1985). Morbidade da doenca de Chagas. III. Estudo long-itudinal de seis anos, em Virgen da Lapa, MG, Brasil. Memórias do Institut° Oswaldo Cruz, 80, 63–71.
   PubMedGoogle Scholar
• Reis, D. D., Jones, E. M., Tostes, S., Lopes, E. R., Chapadeiro, E., Gazinelli, G., Colley, D. G. & McCurley, T. L. (1993). Characterization of inflam-matory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-_+ cells and dominance of granzyme A+, CD8+ lympho-cytes. American Journal of Tropical Medicine and Hygiene, 48, 637–644.
   PubMed Web of Science ®Google Scholar
• Rezende, J. M. & Luquetti, A. O. (1994). Chagasic megavisceras. In Chagas' Disease and the Nervous System, pp. 149-171. Scientific Publication No. 547. Washington, DC: Pan American Health Organization.
   Google Scholar
• Russomando, G., Tomassone, M. M., Guillen, I., Acosta, N., Vera, N., Almiron, M., Candia, N., Calcena, M. F. & Figueredo, A. (1998). Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. American Journal of Tropical Medicine and Hygiene, 59, 487–491.
   PubMed Web of Science ®Google Scholar
• Schmunis, G. A. (1991). Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and non endemic countries. Transfusion, 31, 547–557.
   PubMed Web of Science ®Google Scholar
• Sica, R. E. P. (1986). Involvement of the peripheral sensory nervous system in human chronic Chagas disease. Medicina, 46, 662–668.
   PubMed Web of Science ®Google Scholar
• Sosa Estani, S., Segura, E. L., Ruiz, A. M., Velásquez, E., Porcel, B. M. & Yampotis, C. (1998). Chemotherapy with benznidazole in children in undeterminated phase of Chagas disease. American Journal of Tropical Medicine and Hygiene, 59, 526–529.
   PubMed Web of Science ®Google Scholar
• Souto, R. P., Fernandes, O., Macedo, A. M., Campbell, D. A. & Zingales, B. (1996). DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. Molecular and Biochemical Parasitology, 83, 141-152.
   Google Scholar
• Tibayrenc, M. (1995). Population genetics of parasitic protozoa and other microorganisms. Advances in Parasitology, 36, 47–115.
   PubMedGoogle Scholar
• Tostes S. Jr, Lopes, E. R., Pereira, F. E. L. & Chapadeiro, E. (1994). Miocardite chagasica cronica humana: estudo quantitativo dos linfocitos CD4+ e dos CD8+ no exsudato inflamatório. Revista da Sociedade Brasilera de Medicina Tropical, 27, 127-134.
   Google Scholar
• Urbina, J. A. (1999). Chemotherapy of Chagas disease: the how and the why. Journal of Molecular Medicine, 77, 332–338.
   PubMed Web of Science ®Google Scholar
• Vago, A. R. (1996). PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease. Lancet, 348, 891.
   PubMed Web of Science ®Google Scholar
• Vago, A. R., Andrade, L. O., Leite, A. A., d'Avila Reis, D., Macedo, A. M., Adad, S. J., Tostes, S. Jr, Moreira, M. C., Filho, G. B. & Pena, S. D. (2000). Genetic characterization of T. cruzi directly from tissues of patients with chronic Chagas' disease. Differential distribution of genetic types into diverse organs. American Journal of Pathology, 156, 1805–1809.
   Google Scholar
• Viotti, R. C., Vigliano, C., Armenti, H. & Segura, E. (1994). Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. American Heart Journal, 127, 151.
   PubMed Web of Science ®Google Scholar
• World Health Organization (1991). Special Programme for Research and Training in Tropical Diseases, Eleventh Programme Report. Geneva: WHO.
   Google Scholar
• World Health Organization (1994). Protocolo de evaluación de efecto insecticida sobre Triatominos. Acta Toxicológica Argentina, 2, 29–32.
   Google Scholar
• World Health Organization (1998a). 51st World Health Assembly, Resolution WHA51. 14. Geneva: WHO.
   Google Scholar
• World Health Organization (1998b). Chagas disease. Interruption of transmission in Uruguay. Weekly Epidemiological Record, 73, 1–4.
   PubMedGoogle Scholar
• World Health Organization (1999). Chagas disease. Interruption of transmission in Chile. Weekly Epidemiological Record, 74, 9–11.
   Google Scholar
• World Health Organization (2000). Chagas disease. Certification of interruption of transmission in Chile. Weekly Epidemiological Record, 75, 10–12.
   PubMedGoogle Scholar
• World Health Organization (2002). Report of the Expert Committee on the Control of Chagas Disease. Technical Report Series No. 905. Geneva: WHO.
   Google Scholar
• Zingales, B., Pereira, M. E., Oliveira, R. P., Almeida, K. A., Umezawa, E. S., Souto, R. P., Vargas, N., Cano, M. I., da Silveira, J. F., Nehme, N. S., Morel, C. M., Brener, Z. & Macedo, A. (1997). Trypanosoma cruzi genome project: biological characteristics and molecular typing of clone CL Brener. Acta Tropica, 68, 159–173.
   PubMed Web of Science ®Google Scholar
• Zingales, B., Souto, R. P., Mangia, R. H., Lisboa, C. V., Campbell, D. A., Coura, J. R., Jansen, A. & Fernandes, O. (1998). Molecular epidemiology of American trypanosomiasis in Brazil based on dimorphisms of rRNA and mini-exon gene sequences. International, Journal for Parasitology, 28, 105–112.
   PubMed Web of Science ®Google Scholar